Profile data is unavailable for this security.
About the company
Thalys Medical Technology Group Corp, formerly Thalys Medical Technology Inc, is a China-based company principally engaged in the provision of intensified distribution business and simple sales business and the research, design, manufacture and distribution of independent in vitro diagnostic products. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The Company mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.
- Revenue in CNY (TTM)2.05bn
- Net income in CNY-140.51m
- Incorporated2004
- Employees1.41k
- LocationThalys Medical Technology Group CorpNo.1310 Jinshan AvenueDongxi Lake DistrictWUHAN 430040ChinaCHN
- Phone+86 2 783386378
- Fax+86 2 783084202
- Websitehttps://www.thalys.net.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Nanfang Medical Co Ltd | 513.15m | -152.60m | 1.17bn | 858.00 | -- | 2.45 | -- | 2.27 | -0.5281 | -0.5281 | 1.77 | 1.63 | 0.3732 | 1.68 | 3.23 | 598,071.00 | -11.09 | -1.09 | -26.74 | -2.00 | 7.70 | 20.14 | -29.71 | -1.91 | 0.3585 | -12.20 | 0.5143 | -- | 10.03 | 4.57 | -906.35 | -- | -3.18 | -- |
| CareRay Digital Medical Technology CoLtd | 276.59m | 23.25m | 1.18bn | 252.00 | 50.94 | 1.39 | -- | 4.28 | 0.2638 | 0.2638 | 3.14 | 9.70 | 0.3037 | 1.47 | 4.51 | 1,097,595.00 | 2.56 | 6.65 | 2.73 | 7.37 | 39.84 | 41.17 | 8.41 | 15.64 | 11.20 | -- | 0.006 | 27.61 | 33.81 | 5.17 | 374.05 | -20.74 | 77.38 | -- |
| Touchstone International Medi Sci Co Ltd | 254.39m | 46.96m | 1.33bn | 243.00 | 26.18 | 2.32 | -- | 5.23 | 0.6264 | 0.6264 | 3.36 | 7.08 | 0.4371 | 3.37 | 28.08 | 1,046,885.00 | 8.07 | 10.09 | 8.66 | 10.82 | 55.49 | 57.59 | 18.46 | 20.17 | 9.45 | -- | 0.0031 | 24.66 | 9.31 | 16.34 | 9.53 | 15.39 | -2.39 | -- |
| Thalys Medical Technology Group Corp | 2.05bn | -140.51m | 1.35bn | 1.41k | -- | 1.12 | -- | 0.6599 | -0.8515 | -0.8515 | 11.25 | 5.97 | 0.5812 | 3.88 | 1.24 | 1,456,036.00 | -3.86 | -0.8933 | -7.08 | -1.62 | 19.24 | 22.12 | -6.63 | -1.49 | 1.47 | -1.09 | 0.4509 | -- | -13.10 | 8.77 | -2.69 | -- | -19.20 | -- |
| HOB Biotech Group Corp Ltd | 399.23m | 45.58m | 1.56bn | 550.00 | 34.28 | 1.91 | -- | 3.91 | 0.7228 | 0.7228 | 6.33 | 12.97 | 0.4194 | 1.40 | 10.29 | 725,874.40 | 4.79 | 9.94 | 5.64 | 12.10 | 61.81 | 65.30 | 11.42 | 19.53 | 1.08 | -- | 0.0936 | 32.59 | 23.10 | 14.38 | 13.64 | 3.34 | 46.19 | -- |
| Guangzhou Jet Bio-Filtration Co Ltd | 487.09m | 51.76m | 1.62bn | 1.09k | 30.41 | 1.40 | -- | 3.33 | 0.3805 | 0.3805 | 3.62 | 8.26 | 0.3051 | 3.08 | 5.08 | 446,463.00 | 3.26 | 9.35 | 3.48 | 10.39 | 31.00 | 36.76 | 10.69 | 17.89 | 6.86 | 9.15 | 0.2319 | 29.64 | -24.06 | 17.42 | -60.34 | -8.02 | 47.32 | -- |
| Allgens Medical Technology Co Ltd | 226.03m | 42.66m | 1.85bn | 202.00 | 42.67 | 1.30 | -- | 8.19 | 0.3199 | 0.3199 | 1.70 | 10.47 | 0.151 | 1.42 | 3.98 | 1,118,950.00 | 2.78 | 7.62 | 2.90 | 8.30 | 80.57 | 83.60 | 18.40 | 39.05 | 35.91 | -- | 0.0354 | 5.25 | -7.68 | 12.86 | -43.04 | 10.46 | -26.12 | -- |
Data as of May 31 2024. Currency figures normalised to Thalys Medical Technology Group Corp's reporting currency: Chinese Yuan Renminbi CNY
2.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 996.70k | 1.04% |
| CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 793.70k | 0.83% |
| Goldstate Capital Fund Management Co., Ltd.as of 31 Dec 2023 | 566.40k | 0.59% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 167.20k | 0.17% |
| Fortune & Royal Asset Management Co., Ltd.as of 31 Dec 2023 | 12.40k | 0.01% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 4.80k | 0.01% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
